American Heart Journal
Volume 145, Issue 6 , Pages 971-978, June 2003

What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?☆

  • Steven Steinhubl, MD

      Affiliations

    • University of North Carolina, Chapel Hill, NC, USA
    • Corresponding Author InformationReprint requests: Steven Steinhubl, MD, Division of Cardiology, University of North Carolina, CB#7075, 338 Burnett-Womack Building, Chapel Hill, NC 27599-7075, USA.
    • ,
  • Peter Berger, MD

      Affiliations

    • Mayo Clinic, Rochester, Minn, USA

Received 13 May 2002; accepted 14 October 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by an unrestricted educational grant from Sanofi-Synthelabo and Bristol-Myers Squibb Company.

PII: S0002-8703(03)00104-2

doi:10.1016/S0002-8703(03)00104-2

American Heart Journal
Volume 145, Issue 6 , Pages 971-978, June 2003

Article Tools

* Image Usage & Resolution